This is a preliminary programme. More details and updates will follow in the coming months.

DAY 1 - Wednesday 2 December 2026

changes may occur

13:00-14:00 | Lunch
14:00-14:15 | Official opening

Katharina Brück & Michiel van der Heijden

14:15-15:15 | Multidisciplinary discussion: Perioperative decision-making in muscle-invasive UCa

Moderation: Ignacio Durán

  • Setting the scene - Thomas Powles 
  • Case discussion and Q&A
    • Case presenter: Sara Membribes
      Panel: Valérie Fonteyne, Kilian Gust, Thomas Powles, Bernadett Szabados, Michiel van der Heijden 
15:15-16:00 | The clinician’s AI toolbox: Transforming bladder cancer practice

Moderation: TBD

  • When AI meets the pathologist - Eva Compérat 
  • When AI meets the urologist
  • When AI meets the clinical oncologist - Peter Hoskin 
  • When AI meets the radiologist - Emanuele Messina 
  • Discussion and Q&A - All
16:00-16:30 | Break
16:30-18:00 | Case discussion session: mUCa

Moderation: Ananya Choudhury & Thomas Powles 

Panel: Philippe Barthélémy, Ananya Choudhury, Maria De Santis, Valérie Fonteyne, Petros Grivas, Peter Hoskin, Rob Jones, Sara Membribes, Bernadett Szabados, Michiel van der Heijden

  • Case presentation - Constance Huck, Sara Membribes, Henning Plage 
  • Debate on oligometastatic disease: When to localise and when to systematise? - Valérie Fonteyne, Michiel van der Heijden 
  • Beyond urothelial: Histological subtypes in metastatic bladder cancer - Peter Hoskin
  • Treatment sequencing after EV+P - Philippe Barthélémy 
  • Discussion and Q&A - All

DAY 2 - Thursday 3 December 2026

changes may occur

08:30-09:30 | Industry-sponsored satellite symposium
09:30-10:00 | Break
10:00-10:30 | Update lecture: High-risk, BCG-naïve NMIBC: Where do we stand today?

Moderation: Laura Mertens

  • Where do we stand today? - Félix Guerrero-Ramos 
  • Case discussion and Q&A - Félix Guerrero-Ramos, Maria De Santis 
10:30-11:00 | Update lecture: HER2-directed ADCs: From mechanism to management

Moderation: Maria De Santis

  • HER2 biology and biomarker testing - Eva Compérat
  • Clinical evidence for HER2-directed ADCs - Petros Grivas
  • Case discussion and Q&A - Eva Compérat, Petros Grivas 
11:00-12:30 | Clinical debates: Expert advice in action

Moderation: TBD & Sara Membribes

  • Preserve or excise? Post-neoadjuvant dilemmas in MIBC - Ananya Choudhury, Petros Grivas, Félix Guerrero-Ramos
  • BCG at the crossroads: Future or fade-out in high-risk NMIBC? - Kilian Gust, Laura Mertens 
  • Histological subtypes (excl. neuroendocrine) in MIBC: One-size-fits-all or not? - Rob Jones, Géraldine Pignot 
12:30-13:45 | Lunch
13:00-13:40 | Industry-sponsored satellite symposium
13:45-15:00 | Case discussion session: NMIBC

Moderation: Maria De Santis & Laura Mertens

Panel: Vérane Achard, Ananya Choudhury, Petros Grivas, Félix Guerrero-Ramos, Peter Hoskin, Kilian Gust, Laura Mertens, Géraldine Pignot, Henning Plage, Rik Somford, Toine van der Heijden

  • Case presentation - Constance Huck & Giovanna Pecoraro 
  • Diagnosis, risk stratification and BCG failure in NMIBC - Henning Plage
  • BCG-refractory NMIBC in transition: Emerging evidence and new treatment pathways - Toine van der Heijden
  • RT for NMIBC: Current evidence and future directions - Vérane Achard 
  • Discussion and Q&A - All
15:00-15:40 | Clinical trial journeys in high-risk NMIBC: Nurse and patient perspectives

Moderation: Bernadett Szabados 

  • Beyond the protocol: The nurse's role in supporting patients in trials and on novel treatments - Brett Dawson
  • Living with high-risk NMIBC: A patient's journey through trial and treatment - Kenneth Emberson 
  • Discussion and Q&A - All
15:40-16:05 | Break
16:05-16:35 | Multidisciplinary discussion: Biomarker guided decisions in clinical practice

Moderation: Toine van der Heijden & Ursula Vogl

Panel: Eva Compérat, Sara Membribes, Bernadett Szabados

16:35-18:00 | Case discussion session: MIBC and UTUC

Moderation: Valérie Fonteyne & Henning Plage

Panel: Katharina Brück, Ananya Choudhury, Maria De Santis, Valérie Fonteyne, Félix Guerrero-Ramos, Kilian Gust, Peter Hoskin, Rob Jones, Géraldine Pignot, Bernadett Szabados, Toine van der Heijden 

  • Case presentation - Giovanna Pecoraro & Constance Huck
  • Radical cystectomy in localised, locally advanced and oligometastatic bladder cancer - Toine van der Heijden 
  • TMT: From indication to execution - Katharina Brück
  • Surgical management of UTUC: Choosing the right approach - Géraldine Pignot 
  • Applying perioperative strategies for UTUC in practice - Bernadett Szabados 
  • Discussion and Q&A  - All
18:00-18:05 | Closing remarks